160 related articles for article (PubMed ID: 12136073)
21. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
22. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
23. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
[TBL] [Abstract][Full Text] [Related]
24. Antiglycosphingolipid immune responses in neurology. The Vienna experience with isotypes, subclasses, and disease.
Gatterbauer B; Neisser A; Bernheimer H; Schwerer B
Ann N Y Acad Sci; 1998 Jun; 845():353-62. PubMed ID: 9668368
[TBL] [Abstract][Full Text] [Related]
25. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.
Ang CW; Noordzij PG; de Klerk MA; Endtz HP; van Doorn PA; Laman JD
Infect Immun; 2002 Sep; 70(9):5081-5. PubMed ID: 12183556
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, antigenic specificity, and bactericidal activity of poultry anti-Campylobacter maternal antibodies.
Sahin O; Zhang Q; Meitzler JC; Harr BS; Morishita TY; Mohan R
Appl Environ Microbiol; 2001 Sep; 67(9):3951-7. PubMed ID: 11525990
[TBL] [Abstract][Full Text] [Related]
27. [Antiganglioside antibodies in neuropathies and motor neuronopathies].
Gallardo E; Serrano C; Prat C; Illa I
Neurologia; 1996 Dec; 11 Suppl 5():75-80. PubMed ID: 9044577
[TBL] [Abstract][Full Text] [Related]
28. Cranial polyneuropathy with elevated serum antiganglioside antibody.
Matsubara K; Nigami H; Harigaya H; Baba K
Pediatr Neurol; 1997 Feb; 16(2):149-51. PubMed ID: 9090691
[TBL] [Abstract][Full Text] [Related]
29. Three patients with ophthalmoplegia associated with Campylobacter jejuni.
Kuroki S; Saida T; Nukina M; Yoshioka M; Seino J
Pediatr Neurol; 2001 Jul; 25(1):71-4. PubMed ID: 11483401
[TBL] [Abstract][Full Text] [Related]
30. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?
Berciano J; Illa I
Neurology; 2005 Feb; 64(4):766-7; author reply 766-7. PubMed ID: 15728323
[No Abstract] [Full Text] [Related]
31. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
[TBL] [Abstract][Full Text] [Related]
32. Campylobacter jejuni-induced acute transverse myelitis.
Baar I; Jacobs BC; Govers N; Jorens PG; Parizel PM; Cras P
Spinal Cord; 2007 Oct; 45(10):690-4. PubMed ID: 17297497
[TBL] [Abstract][Full Text] [Related]
33. Pre-exposure anti-Campylobacter jejuni immunoglobulin a levels associated with reduced risk of Campylobacter diarrhea in adults traveling to Thailand.
Walz SE; Baqar S; Beecham HJ; Echeverria P; Lebron C; McCarthy M; Kuschner R; Bowling S; Bourgeois AL; Scott DA
Am J Trop Med Hyg; 2001 Nov; 65(5):652-6. PubMed ID: 11716132
[TBL] [Abstract][Full Text] [Related]
34. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease.
Taylor BV; Williamson J; Jones D; Coleman D; Luck J; McGregor A
J Clin Neurosci; 2007 Feb; 14(2):116-21. PubMed ID: 17107803
[TBL] [Abstract][Full Text] [Related]
35. Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy.
van Eijk JJ; van Alfen N; Tio-Gillen AP; Maas M; Herbrink P; Portier RP; van Doorn PA; van Engelen BG; Jacobs BC
J Peripher Nerv Syst; 2011 Jun; 16(2):153-6. PubMed ID: 21692917
[No Abstract] [Full Text] [Related]
36. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin G response in patients with Campylobacter concisus diarrhea.
Nielsen HL; Kaakoush NO; Mitchell HM; Nielsen H
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):151-4. PubMed ID: 26643061
[TBL] [Abstract][Full Text] [Related]
38. Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, Turkey.
Porter CK; El Mohammady H; Baqar S; Rockabrand DM; Putnam SD; Tribble DR; Riddle MS; Frenck RW; Rozmajzl P; Kilbane E; Fox A; Ruck R; Lim M; Johnston YJ; Murphy E; Sanders JW
Clin Vaccine Immunol; 2008 Dec; 15(12):1884-7. PubMed ID: 18845833
[TBL] [Abstract][Full Text] [Related]
39. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a non-human primate Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine formulations.
Islam D; Lewis MD; Srijan A; Bodhidatta L; Aksomboon A; Gettayacamin M; Baqar S; Scott D; Mason CJ
Vaccine; 2006 May; 24(18):3762-71. PubMed ID: 16098634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
